HSD17B13 and hepatocellular carcinoma: Genetic polymorphisms in several genes have been associated with an increased risk of HCC, including variants in PNPLA3, TM6SF2, GCKR, and MBOAT; meanwhile, HSD17B13 variants decreased the risk of HCC [78,79,80].